Our study evaluated the effects of trans-chalcone and silibinin on AD model animals and revealed that simultaneous intra-hippocampal injection of trans-chalcone or silibinin with insulin fibril was effective in improving the symptoms of induced AD, although both compounds were more effective if present at the time of insulin fibril formation. This evidence concerns the gene INS and Alzheimer disease.